H
Harvest
Tax-loss replacement research
CYTK
Cytokinetics
Health CareBiotechnologyBiotechnology
28 stocks · 12 ETFs
data as of Aug 24, 2026
REPLACEMENT RESEARCH

Tax-loss harvesting alternatives for CYTK

Among the 28 Biotechnology peers screened, UTHR (United Therapeutics) has tracked CYTK most closely over the past year, with a return correlation of 0.51. The strongest fund stand-in is XBI (SPDR S&P Biotech ETF) at 0.47 over the past year. Correlations are computed from daily closing-price returns aligned by trading day.

Run this search live in the Screener →
STOCKS

Single-name peers

TickerNameSub-industry1Y3Y5Y10Y
UTHRUnited TherapeuticsBiotechnology0.510.240.230.25
ARWRArrowhead PharmaceuticalsBiotechnology0.380.270.330.27
ROIVRoivant SciencesBiotechnology0.270.270.20
VRTXVertex PharmaceuticalsBiotechnology0.270.170.190.23
LGNDLigand Pharmaceuticals, Inc.Biotechnology0.260.240.290.30
RCUSArcus Biosciences, Inc.Biotechnology0.250.240.280.24
XNCRXencor IncBiotechnology0.250.220.280.30
VIRVir Biotechnology, Inc.Biotechnology0.230.190.190.13
BIIBBiogen Inc.Biotechnology0.220.210.220.23
KRYSKrystal BiotechBiotechnology0.210.240.220.21
NBIXNeurocrine BiosciencesBiotechnology0.200.190.240.25
TGTXTG Therapeutics, Inc.Biotechnology0.180.160.240.24
SRPTSarepta TherapeuticsBiotechnology0.180.150.200.22
FTREFortreaBiotechnology0.170.190.19
AMGNAmgen Inc.Biotechnology0.160.190.180.25
HRMYHarmony Biosciences Holdings, Inc.Biotechnology0.160.120.18
EXELExelixisBiotechnology0.160.120.200.24
BMRNBioMarin PharmaceuticalBiotechnology0.160.200.260.28
RGENRepligenBiotechnology0.150.180.230.24
PTGXProtagonist Therapeutics, Inc.Biotechnology0.150.170.180.16
INCYIncyteBiotechnology0.130.170.190.23
REGNRegeneron PharmaceuticalsBiotechnology0.120.180.190.22
ALNYAlnylam PharmaceuticalsBiotechnology0.110.160.200.22
MRNAModerna Inc.Biotechnology0.100.120.120.12
GILDGilead SciencesBiotechnology0.100.120.130.16
VCELVericelBiotechnology0.090.130.240.22
ADMAADMA Biologics, Inc.Biotechnology0.090.170.230.21
HALOHalozymeBiotechnology0.080.130.210.25
ETFS

Fund stand-ins

An ETF is generally not 'substantially identical' to a single stock, which is why funds are the standard wash-sale-aware replacement.

TickerNameFocusMatch1Y3Y5Y10Y
XBISPDR S&P Biotech ETFBiotechnology (Equal Wt)INDUSTRY0.470.420.480.46
IBBiShares Biotechnology ETFBiotechnologyINDUSTRY0.400.380.420.43
XPHSPDR S&P PharmaceuticalsPharmaceuticals (Equal Wt)INDUSTRY0.350.310.380.37
IHEiShares US Pharmaceuticals ETFPharmaceuticalsINDUSTRY0.290.260.290.32
ARKGARK Genomic Revolution ETFGenomics (Active)INDUSTRY0.280.280.360.37
VHTVanguard Health Care ETFHealth Care SectorSECTOR0.240.260.300.33
FHLCFidelity MSCI Health Care ETFHealth Care SectorSECTOR0.240.260.300.32
PPHVanEck Pharma ETFPharmaceuticalsINDUSTRY0.230.210.230.27
IYHiShares US Healthcare ETFHealth Care SectorSECTOR0.210.240.270.30
XLVHealth Care Select Sector SPDRHealth Care SectorSECTOR0.190.230.250.28
IHIiShares Medical Devices ETFMedical DevicesSUB-IND0.080.150.220.26
IHFiShares Health Care ProvidersHealth Care ProvidersINDUSTRY0.030.120.200.24
NEXT STEPS

Harvesting a loss in CYTK?

RELATED

Replacement research for CYTK's peers

Browse all tickers →

Method: Pearson correlation of daily closing-price returns, Yahoo Finance data, series aligned by trading day, refreshed weekly. A cell is blank when overlapping history covers less than 60% of its window. Correlation is descriptive, not predictive. Wash-sale treatment depends on facts and circumstances — confirm with a tax professional. Not investment advice.